BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33993340)

  • 1. Selective involution of thymic medulla by cyclosporine A with a decrease of mature thymic epithelia, XCR1
    Sawanobori Y; Kitazawa Y; Ueta H; Matsuno K; Tokuda N
    Histochem Cell Biol; 2021 Aug; 156(2):133-146. PubMed ID: 33993340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of X-irradiation and cyclosporin-A administration on the thymus with respect to the generation of cyclosporin-A-induced autoimmunity.
    Beijleveld LJ; Damoiseaux JG; Van Breda Vriesman PJ
    Dev Immunol; 1995; 4(2):127-38. PubMed ID: 9700362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of semiallogeneic dendritic cells to the thymus during post-cyclosporine thymic regeneration.
    Beschorner WE; Yao X; Divic J
    Transplantation; 1995 Dec; 60(11):1326-30. PubMed ID: 8525529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor I.
    Beschorner WE; Divic J; Pulido H; Yao X; Kenworthy P; Bruce G
    Transplantation; 1991 Nov; 52(5):879-84. PubMed ID: 1949174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine and the thymus: influence of irradiation and age on thymic immunopathology and recovery.
    Beschorner WE; Di Gennaro KA; Hess AD; Santos GW
    Cell Immunol; 1987 Dec; 110(2):350-64. PubMed ID: 3500795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin antagonises the cyclosporine A immunosuppressive effects in rat thymuses.
    Rezzani R; Rodella L; Bianchi R
    Int Immunopharmacol; 2001 Aug; 1(8):1615-9. PubMed ID: 11515824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to cyclosporin A-induced autologous graft-versus-host disease is mediated by a CD4+CD25+ subset of recent thymic emigrants.
    Wu DY; Goldschneider I
    J Immunol; 2001 Jun; 166(12):7158-64. PubMed ID: 11390462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A-induced changes of the thymic microenvironment. A review of morphological studies.
    Milićević NM; Milićević Z
    Histol Histopathol; 1998 Oct; 13(4):1183-96. PubMed ID: 9810510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of dendritic cells in the rat thymus without epithelial cell loss during cyclosporine treatment and recovery.
    De Waal EJ; Rademakers LH; Schuurman HJ; Vos JG; Van Loveren H
    Toxicology; 1996 Jun; 110(1-3):133-51. PubMed ID: 8658554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.
    Coquet JM; Ribot JC; Bąbała N; Middendorp S; van der Horst G; Xiao Y; Neves JF; Fonseca-Pereira D; Jacobs H; Pennington DJ; Silva-Santos B; Borst J
    J Exp Med; 2013 Apr; 210(4):715-28. PubMed ID: 23547099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression with cyclosporin A alters the thymic microenvironment.
    Kanariou M; Huby R; Ladyman H; Colic M; Sivolapenko G; Lampert I; Ritter M
    Clin Exp Immunol; 1989 Nov; 78(2):263-70. PubMed ID: 12412760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients.
    Hoerning A; Köhler S; Jun C; Lu J; Fu J; Tebbe B; Dolff S; Feldkamp T; Kribben A; Hoyer PF; Witzke O
    Clin Exp Immunol; 2012 May; 168(2):251-9. PubMed ID: 22471287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, bis(tri-n-butyltin) oxide and cyclosporine on thymus histophysiology.
    De Waal EJ; Schuurman HJ; Van Loveren H; Vos JG
    Crit Rev Toxicol; 1997 Jul; 27(4):381-430. PubMed ID: 9263645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal differentiation of thymocytes induced by free cyclosporine is avoided when cyclosporine bound to N-(2-hydroxypropyl)methacrylamide copolymer carrier is used.
    St'astný M; Ulbrich K; Strohalm J; Rossmann P; Ríhová B
    Transplantation; 1997 Jun; 63(12):1818-27. PubMed ID: 9210511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of in vivo cyclosporin A administration on rat thymic dendritic cells.
    Damoiseaux JG; Beijleveld LJ; van Breda Vriesman PJ
    Clin Exp Immunol; 1994 Jun; 96(3):513-20. PubMed ID: 8004822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined Cyclosporine A and liposome encapsulated dichloromethylene diphosphonate on the organisation of the rat thymus: evidence for a role of macrophages in guiding the post Cyclosporine A thymic reorganisation.
    Rezzani R; Rodella L; Bianchi R
    Int J Immunopharmacol; 1998; 20(4-5):183-92. PubMed ID: 9730254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
    Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
    Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants.
    Wu DY; Goldschneider I
    J Immunol; 1999 Jun; 162(11):6926-33. PubMed ID: 10352315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thymus and prolonged administration of cyclosporine. Irreversible immunopathologic changes associated with autologous pseudo-graft-versus-host disease.
    Shinozawa T; Beschorner WE; Hess AD
    Transplantation; 1990 Jul; 50(1):106-11. PubMed ID: 2114678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells.
    Garg G; Nikolouli E; Hardtke-Wolenski M; Toker A; Ohkura N; Beckstette M; Miyao T; Geffers R; Floess S; Gerdes N; Lutgens E; Osterloh A; Hori S; Sakaguchi S; Jaeckel E; Huehn J
    Oncotarget; 2017 May; 8(22):35542-35557. PubMed ID: 28415767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.